Innovation conferences play an important role in fostering exchange between startups, investors, and industry stakeholders, creating opportunities to discuss emerging technologies and the challenges of scaling early-stage companies. Fetalix participated in SIM Conference, where the team engaged with the broader innovation ecosystem through the startup showcase and discussions with fellow founders and investors.
During the event, Fetalix presented its regenerative biomaterial technology for intervertebral disc degeneration and low back pain, contributing to conversations around deep-tech innovation, healthcare solutions, and the translation of scientific research into market applications.
The conference also featured talks and workshops addressing entrepreneurship, innovation strategy, and ecosystem development, offering insights into the evolving landscape of startup growth and investment. It provided an opportunity to engage in broader discussions on innovation and to strengthen connections within the European startup and investment ecosystem.
Fetalix’s presence at SIM Conference reflects its continued engagement with international innovation networks.
May 15, 2026
